normalized rnaseq data (Partek)
Structured Review

Normalized Rnaseq Data, supplied by Partek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/normalized rnaseq data/product/Partek
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "An Interleukin-15 Superagonist Enables Antitumor Efficacy of Natural Killer Cells Against All Molecular Variants of SCLC"
Article Title: An Interleukin-15 Superagonist Enables Antitumor Efficacy of Natural Killer Cells Against All Molecular Variants of SCLC
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
doi: 10.1016/j.jtho.2022.11.008
Figure Legend Snippet: Neuroendocrine SCLC express fewer factors that are inhibitory to NK cells. ( A ) Immunofluorescent staining of NCAM1 and MHC-class I proteins in SCLC tissues of a tumor microarray (NCAM1 = red, MHC-class I = white, DAPI = blue). Images representing tumor cases that are POS for NCAM1 and NEG for MHC-class I; double POS for NCAM1 and MHC-class I; NCAM1 NEG/MHC-class I POS; and double NEG for NCAM1 and MHC-class I. ( B ) Quantification of 80 SCLC tumors scored based on positivity for NCAM1 and MHC-class I expression. ( C ) Immunofluorescent staining of ASCL1, NEUROD1, POU2F3, YAP1, and MHC-class I in SCLC tissues of a tumor microarray (ASCL1 = turquoise, NEUROD1 = green, POU2F3 = pink, YAP1 = red, MHC-class I = white, DAPI = blue). Images representing a tumor classified as each of the four subtypes of SCLC. ( D ) Quantification of 79 evaluable tumors based on the predominant transcription factor expression and MHC-class I within each case. ( E ) SCLC tissues of a tumor microarray were analyzed by RNA in situ hybridization for the presence of NK cells. Representative image depicting RNA in situ hybridization staining of CD49b mRNA (pink) and NCR3 mRNA (NKp30, green). ( F ) Quantification displays the number of NK cells per 1000 DAPI POS cells within a standardized ROI; analysis completed on ASCL1 POS MHC-class I NEG , ASCL1 POS MHC-class I POS , NEUROD1 POS , POU2F3 POS (n = 5 tissues each), and YAP1 POS (n = 2 tissues). *p < 0.05 by one-way ANOVA with Tukey’s multiple comparison post-test. ( G ) Heatmap expression of ASCL1, NEUROD1, POU2F3, YAP1, and genes relevant to NK activity in 88 SCLC tumor biopsies obtained from 62 patients with metastatic SCLC previously analyzed by RNAseq analysis (NE = grey, non-NE = black, ASCL1 = purple, NEUROD1 = orange, POU2F3 = blue, YAP1 = green). ( H ) Heatmap of expression of selected NK activating and NK inhibitory ligand genes as determined by quantitative reverse transcription PCR across a panel of SCLC cell lines (NE = neuroendocrine; non-NE = non-neuroendocrine). Values illustrated correspond to log 2 -transformed gene expression relative to the control gene GAPDH in each cell line. ( I ) Neuroendocrine (DMS79, H69) and non-neuroendocrine (DMS114, H841) SCLC cells were assayed for susceptibility to NK cells at an E:Tratio of 10:1 in a 24-hour assay. **** p < 0.0001 comparing NE versus non-NE by unpaired t test. Data illustrated are representative of n = 8 healthy NK donors. #, number; ANOVA, analysis of variance; DAPI, ′,6-diamidino-2-phenylindole; E:T, effector-to-target; NE, neuroendocrine; NEG, negative; NK, natural killer; PCR, polymerase chain reaction; POS, positive; ROI, region of interest.
Techniques Used: Staining, Microarray, Expressing, RNA In Situ Hybridization, Comparison, Activity Assay, Reverse Transcription, Transformation Assay, Gene Expression, Control, Polymerase Chain Reaction

